Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study

Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study

(1) Objective: The aim of this dynamic LC-MS (liquid chromatography and mass spectrometry) human platelet proteomic study was to identify the potential proteins candidates for biomarkers of acute ischemic stroke (AIS), their changes during the acute phase of stroke and to define potential novel drug...

Full description

Bibliographic Details
Main Authors: Karolina Gawryś, Aleksandra Turek-Jakubowska, Jakub Gawryś, Maciej Jakubowski, Janusz Dębski, Ewa Szahidewicz-Krupska, Małgorzata Trocha, Arkadiusz Derkacz, Adrian Doroszko
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
stroke
platelet proteome
biomarkers
platelets
thymidine phosphorylase 4
proteomics
Online Access:https://www.mdpi.com/2077-0383/11/5/1198

Similar Items

Similar Items